Your browser doesn't support javascript.
loading
Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Routy, Bertrand; Lenehan, John G; Miller, Wilson H; Jamal, Rahima; Messaoudene, Meriem; Daisley, Brendan A; Hes, Cecilia; Al, Kait F; Martinez-Gili, Laura; Puncochár, Michal; Ernst, Scott; Logan, Diane; Belanger, Karl; Esfahani, Khashayar; Richard, Corentin; Ninkov, Marina; Piccinno, Gianmarco; Armanini, Federica; Pinto, Federica; Krishnamoorthy, Mithunah; Figueredo, Rene; Thebault, Pamela; Takis, Panteleimon; Magrill, Jamie; Ramsay, LeeAnn; Derosa, Lisa; Marchesi, Julian R; Parvathy, Seema Nair; Elkrief, Arielle; Watson, Ian R; Lapointe, Rejean; Segata, Nicola; Haeryfar, S M Mansour; Mullish, Benjamin H; Silverman, Michael S; Burton, Jeremy P; Maleki Vareki, Saman.
Afiliação
  • Routy B; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Lenehan JG; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
  • Miller WH; Department of Oncology, Western University, London, Ontario, Canada.
  • Jamal R; Lawson Health Research Institute, London, Ontario, Canada.
  • Messaoudene M; Lady Davis Institute of the Jewish General Hospital, Segal Cancer Centre, Montreal, Quebec, Canada.
  • Daisley BA; Departments of Oncology and Medicine, McGill University, Montreal, Quebec, Canada.
  • Hes C; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Al KF; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
  • Martinez-Gili L; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Puncochár M; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.
  • Ernst S; Canadian Centre for Human Microbiome and Probiotics Research, London, Ontario, Canada.
  • Logan D; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Belanger K; Peter Brojde Lung Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada.
  • Esfahani K; Lawson Health Research Institute, London, Ontario, Canada.
  • Richard C; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.
  • Ninkov M; Canadian Centre for Human Microbiome and Probiotics Research, London, Ontario, Canada.
  • Piccinno G; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, St Mary's Hospital Campus, Imperial College London, London, UK.
  • Armanini F; Section of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
  • Pinto F; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.
  • Krishnamoorthy M; Department of Oncology, Western University, London, Ontario, Canada.
  • Figueredo R; Department of Oncology, Western University, London, Ontario, Canada.
  • Thebault P; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Takis P; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
  • Magrill J; Lady Davis Institute of the Jewish General Hospital, Segal Cancer Centre, Montreal, Quebec, Canada.
  • Ramsay L; Departments of Oncology and Medicine, McGill University, Montreal, Quebec, Canada.
  • Derosa L; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Marchesi JR; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.
  • Parvathy SN; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.
  • Elkrief A; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.
  • Watson IR; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.
  • Lapointe R; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Segata N; Department of Oncology, Western University, London, Ontario, Canada.
  • Haeryfar SMM; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Mullish BH; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, National Phenome Centre, Imperial College London, London, UK.
  • Silverman MS; Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Burton JP; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Quebec, Canada.
  • Maleki Vareki S; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Quebec, Canada.
Nat Med ; 30(2): 604, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37923839
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article